Filling the need for trusted information on national health issues…

Trending on kff King v. Burwell Medicaid Expansion Tax Season & the ACA

Kaiser Daily Global Health Policy ReportPrivate Sector Involvement Search Results « » The Henry J. Kaiser Family Foundation

Private Sector Involvement

  • your selections
Clear Search

Filter Results

date

Tags

  • results
Pfizer Ceases Sale Of Children’s Vaccine In China

Agence France-Presse: Pfizer stops sale of children’s vaccine in China “American pharmaceutical giant Pfizer has stopped selling one of its lucrative vaccines for children in China, the company said. Pfizer gave no explanation for stopping its sales of the Prevnar vaccine, which helps prevent infections such as pneumonia, which killed…

Lessons Learned From Ebola Outbreak Demonstrate Importance Of Vaccine Research, Development

Center for Global Health Policy’s “Science Speaks”: Lessons from Ebola: A vaccine fast track too slow demonstrates need to prepare for pandemic potential diseases Elizabeth Bukowski, freelance journalist and veterinarian, reports from the 3rd International One Health Congress in Amsterdam and discusses comments from the director of the Jenner Institute…

Experimental Ebola Vaccine Trials Show Safety Of Drug, Ability To Trigger Immune Response

Media outlets report on results from two Ebola experimental drug trials published in the New England Journal of Medicine on Wednesday. The reports, titled “A Recombinant Vesicular Stomatitis Virus Ebola Vaccine — Preliminary Report” and “Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe — Preliminary Report”, suggest…

System-Wide Change Critical In Efforts Against Antibiotic Drug Resistance

Project Syndicate: A Fair Fight Against Antimicrobial Resistance Gerald Bloom, physician and health economist at the Institute of Development Studies at the University of Sussex “…Meeting the challenge of drug-resistant microbes will be difficult. … Implementing a system-wide change in the use of antibiotics will require the creation of national…

USG Awards Pharmaceutical Company Funds To Develop Ebola Treatment

The Hill: Feds award company up to $35M to develop Ebola drug “The Department of Health and Human Services (HHS) on Tuesday awarded about $12 million to a North Carolina pharmaceutical company that has been developing Ebola treatments. The company, BioCryst Pharmaceuticals, has created a ‘promising’ experimental drug that prevents…

NIH Confirms Safety Of 2 Experimental Ebola Vaccines

Reuters: Two experimental Ebola vaccines pass safety test in African trial “Two experimental Ebola vaccines, one from GlaxoSmithKline PLC and the other from biotech start-up NewLink Genetics Corp, ‘appear to be safe’ part way through a clinical trial being conducted in Liberia, the U.S. National Institutes of Health (NIH) said…

Opinion Pieces Mark World TB Day

Devex: New approaches needed to end TB Anna Nakanwagi-Mukwaya, director of the International Union Against Tuberculosis and Lung Disease’s Uganda office; Paula Fujiwara, the Union’s scientific director; and Lucica Ditiu, executive secretary of the Stop TB Partnership “…Innovative projects like [Slum Partnerships to Actively Respond to Tuberculosis in Kampala (SPARK-TB)],…